R.A. Asherson / R. Cervera / J.C. Piette / Y. Shoenfeld (eds.)
The Antiphospholipid Syndrome II
Autoimmune Thrombosis
Herausgeber: Cervera, R.; Shoenfeld, Yehuda; Piette, J C
R.A. Asherson / R. Cervera / J.C. Piette / Y. Shoenfeld (eds.)
The Antiphospholipid Syndrome II
Autoimmune Thrombosis
Herausgeber: Cervera, R.; Shoenfeld, Yehuda; Piette, J C
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book provides the reader with a comprehensive overview of the Antiphospholipid syndrome. One of the most important advances in rheumatology and connective tissue diseases of the last decade. It provides an explanation for many previously undefined conditions with no clear pathogenesis encompassing all subspeculations in internal medicine as well as obstetrics. Clotting problems leading to strokes and myocardial infarctions (in younger people) as well as a large variety of other syndromes such as chorea, hyproadrenalism, pulmonary problems are now being understood.
Andere Kunden interessierten sich auch für
- Antiphospholipid Syndrome103,99 €
- Antiphospholipid Antibody Syndrome88,99 €
- Antiphospholipid Syndrome81,99 €
- Antiphospholipid Antibody Syndrome74,99 €
- The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part II - Lower Digestive Tract114,99 €
- Diabetes Care for the Older Patient88,99 €
- The Uveitis Atlas28,99 €
-
-
-
This book provides the reader with a comprehensive overview of the Antiphospholipid syndrome. One of the most important advances in rheumatology and connective tissue diseases of the last decade. It provides an explanation for many previously undefined conditions with no clear pathogenesis encompassing all subspeculations in internal medicine as well as obstetrics. Clotting problems leading to strokes and myocardial infarctions (in younger people) as well as a large variety of other syndromes such as chorea, hyproadrenalism, pulmonary problems are now being understood.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Elsevier Science
- 2nd edition
- Seitenzahl: 478
- Erscheinungstermin: 22. August 2002
- Englisch
- Abmessung: 266mm x 197mm x 26mm
- Gewicht: 1279g
- ISBN-13: 9780444509871
- ISBN-10: 0444509879
- Artikelnr.: 21948786
- Verlag: Elsevier Science
- 2nd edition
- Seitenzahl: 478
- Erscheinungstermin: 22. August 2002
- Englisch
- Abmessung: 266mm x 197mm x 26mm
- Gewicht: 1279g
- ISBN-13: 9780444509871
- ISBN-10: 0444509879
- Artikelnr.: 21948786
Preface. Editor biography. List of Contributors. I. History and
Epidemiology of the Antiphospholipid Syndrome (R.A. Asherson). Milestones
in the Antiphospholipid Syndrome (R.A. Asherson et al.). Classification and
Epidemiology of the Antiphospholipid Syndrome (M. Petri). II. Immunology
and Pathophysiology of the Antiphospholipid Syndrome (Y. Shoenfeld). Lupus
Anticoagulant: Detection, Standardization and Heterogeneity (D.A. Triplett,
M.-C. Boffa). Antibodies to Cardiolipin and other Phospholipids (S.S.
Pierangeli, E.N. Harris). &bgr;-Glycoprotein I and anti-&bgr;-Glycoprotein
I Antibodies (P.G. De Groot et al.). Anti-Prothrombin Antibodies (M.
Galli). The Annexins: A Target of Antiphospholipid Antibodies (J.H. Rand,
Xiao-Xuan Wu). Antiphospholipid/Endothelial Cell Interaction in the
Pathogenesis of the Antiphospholipid Syndrome (P.L. Luigi et al.). Tissue
Factor, Protein C pathway and other Hemostasis Abnormalities in the
Pathogenesis of the Antiphospholipid Syndrome (R.A.S. Roubey). Systemic
Involvement in the Antiphospholipid Syndrome: Lessons from Animal Models
(Y. Shoenfeld et al.). Cytokines, Th1/Th2 and Adhesion Molecules in the
Antiphospholipid Syndrome (M. Ehrenfeld et al.). Lessons from Monoclonal
Antiphospholipid Antibodies (M. Abu-Shakra, Y. Shoenfeld). Immunogenetics
of the Antiphospholipid Syndrome (G.D. Sebastiani et al.). Pathology of the
Antiphospholipid Syndrome (E. Reyes, D. Alarcón-Segovia). Antiphospholipid
Antibodies in Human and Murine Atherogenesis (Y. Sherer, Y. Shoenfeld).
III. Clinical Features in the Antiphospholipid Syndrome (R. Cervera).
Thrombotic Manifestations in the Antiphospholipid Syndrome (J.O. Ros et al.
). Neurologic Manifestations in the Antiphospholipid Syndrome (R.L. Brey
et al.). Cardiac and Pulmonary Manifestations in the Antiphospholipid
Syndrome (G. Espinosa et al.). Renal, Hepatic and other Intra-abdominal
Manifestations in the Antiphospholipid Syndrome (P. von Landenberg et al.
). Fetal and Obstetric Manifestations and Infertility in the
Antiphospholipid Syndrome (F. Carmona, J. Balasch). Osteo articular
Manifestations in the Antiphospholipid Syndrome (F. Lioté, O. Meyer).
Ophthalmic and Otological Manifestations in the Antiphospholipid Syndrome
(A. Montehermoso et al.). Dermatologic Manifestations in the
Antiphospholipid Syndrome (C. Frances, J.C. Piette). Endocrine
Manifestations in the Antiphospholipid Syndrome (R.A. Asherson, M. Petri).
Hematological Abnormalities in the Antiphospholipid Syndrome (G. Espinosa
et al.). Immunological Abnormalities in the Antiphospholipid Syndrome (A.
Tincani et al.). ''Primary'', ''Secondary'', ''Seronegative'',
''Catastrophic'' and other Subsets of the Antiphospholipid Syndrome (R.A.
Asherson et al.). Pediatric and Familial Antiphospholipid Syndrome (L.R.
Sammaritano, J.-C. Piette). Antiphospholipid Antibodies and Malignancies
(R.A. Asherson et al.). Antiphospholipid Antibodies and Vasculitis (R.A.
Asherson, R.A. Levy). Antiphospholipid Antibodies and Infections-Drugs (G.
Zandman-Goddard et al.). IV. Management and Prognosis of the
Antiphospholipid Syndrome (J.-C. Piette).
Management of Thrombosis in the Antiphospholipid Syndrome (R.H.W.M. Derksen
et al.). Management of Reproductive Failure in the Antiphospholipid
Syndrome (J. Balasch et al.). Management of the Difficult Aspects of the
Antiphospholipid Syndrome (D. Erkan et al.). Course and Prognosis of the
Antiphospholipid Syndrome (C. Drenkard, D. Alarcón-Segovia). Novel
Perspectives in the Treatment of the Antiphospholipid Syndrome - from
Anticoagulation to Immunomodulation (M. Blank et al.). V. Appendix.
The Antiphospholipid Syndrome in the Internet (M. Ramos-Casals, R.
Cervera). A Patient¿s Guide to the Antiphospholipid Syndrome (J. Berman et
al.). Subject Index.
Epidemiology of the Antiphospholipid Syndrome (R.A. Asherson). Milestones
in the Antiphospholipid Syndrome (R.A. Asherson et al.). Classification and
Epidemiology of the Antiphospholipid Syndrome (M. Petri). II. Immunology
and Pathophysiology of the Antiphospholipid Syndrome (Y. Shoenfeld). Lupus
Anticoagulant: Detection, Standardization and Heterogeneity (D.A. Triplett,
M.-C. Boffa). Antibodies to Cardiolipin and other Phospholipids (S.S.
Pierangeli, E.N. Harris). &bgr;-Glycoprotein I and anti-&bgr;-Glycoprotein
I Antibodies (P.G. De Groot et al.). Anti-Prothrombin Antibodies (M.
Galli). The Annexins: A Target of Antiphospholipid Antibodies (J.H. Rand,
Xiao-Xuan Wu). Antiphospholipid/Endothelial Cell Interaction in the
Pathogenesis of the Antiphospholipid Syndrome (P.L. Luigi et al.). Tissue
Factor, Protein C pathway and other Hemostasis Abnormalities in the
Pathogenesis of the Antiphospholipid Syndrome (R.A.S. Roubey). Systemic
Involvement in the Antiphospholipid Syndrome: Lessons from Animal Models
(Y. Shoenfeld et al.). Cytokines, Th1/Th2 and Adhesion Molecules in the
Antiphospholipid Syndrome (M. Ehrenfeld et al.). Lessons from Monoclonal
Antiphospholipid Antibodies (M. Abu-Shakra, Y. Shoenfeld). Immunogenetics
of the Antiphospholipid Syndrome (G.D. Sebastiani et al.). Pathology of the
Antiphospholipid Syndrome (E. Reyes, D. Alarcón-Segovia). Antiphospholipid
Antibodies in Human and Murine Atherogenesis (Y. Sherer, Y. Shoenfeld).
III. Clinical Features in the Antiphospholipid Syndrome (R. Cervera).
Thrombotic Manifestations in the Antiphospholipid Syndrome (J.O. Ros et al.
). Neurologic Manifestations in the Antiphospholipid Syndrome (R.L. Brey
et al.). Cardiac and Pulmonary Manifestations in the Antiphospholipid
Syndrome (G. Espinosa et al.). Renal, Hepatic and other Intra-abdominal
Manifestations in the Antiphospholipid Syndrome (P. von Landenberg et al.
). Fetal and Obstetric Manifestations and Infertility in the
Antiphospholipid Syndrome (F. Carmona, J. Balasch). Osteo articular
Manifestations in the Antiphospholipid Syndrome (F. Lioté, O. Meyer).
Ophthalmic and Otological Manifestations in the Antiphospholipid Syndrome
(A. Montehermoso et al.). Dermatologic Manifestations in the
Antiphospholipid Syndrome (C. Frances, J.C. Piette). Endocrine
Manifestations in the Antiphospholipid Syndrome (R.A. Asherson, M. Petri).
Hematological Abnormalities in the Antiphospholipid Syndrome (G. Espinosa
et al.). Immunological Abnormalities in the Antiphospholipid Syndrome (A.
Tincani et al.). ''Primary'', ''Secondary'', ''Seronegative'',
''Catastrophic'' and other Subsets of the Antiphospholipid Syndrome (R.A.
Asherson et al.). Pediatric and Familial Antiphospholipid Syndrome (L.R.
Sammaritano, J.-C. Piette). Antiphospholipid Antibodies and Malignancies
(R.A. Asherson et al.). Antiphospholipid Antibodies and Vasculitis (R.A.
Asherson, R.A. Levy). Antiphospholipid Antibodies and Infections-Drugs (G.
Zandman-Goddard et al.). IV. Management and Prognosis of the
Antiphospholipid Syndrome (J.-C. Piette).
Management of Thrombosis in the Antiphospholipid Syndrome (R.H.W.M. Derksen
et al.). Management of Reproductive Failure in the Antiphospholipid
Syndrome (J. Balasch et al.). Management of the Difficult Aspects of the
Antiphospholipid Syndrome (D. Erkan et al.). Course and Prognosis of the
Antiphospholipid Syndrome (C. Drenkard, D. Alarcón-Segovia). Novel
Perspectives in the Treatment of the Antiphospholipid Syndrome - from
Anticoagulation to Immunomodulation (M. Blank et al.). V. Appendix.
The Antiphospholipid Syndrome in the Internet (M. Ramos-Casals, R.
Cervera). A Patient¿s Guide to the Antiphospholipid Syndrome (J. Berman et
al.). Subject Index.
Preface. Editor biography. List of Contributors. I. History and
Epidemiology of the Antiphospholipid Syndrome (R.A. Asherson). Milestones
in the Antiphospholipid Syndrome (R.A. Asherson et al.). Classification and
Epidemiology of the Antiphospholipid Syndrome (M. Petri). II. Immunology
and Pathophysiology of the Antiphospholipid Syndrome (Y. Shoenfeld). Lupus
Anticoagulant: Detection, Standardization and Heterogeneity (D.A. Triplett,
M.-C. Boffa). Antibodies to Cardiolipin and other Phospholipids (S.S.
Pierangeli, E.N. Harris). &bgr;-Glycoprotein I and anti-&bgr;-Glycoprotein
I Antibodies (P.G. De Groot et al.). Anti-Prothrombin Antibodies (M.
Galli). The Annexins: A Target of Antiphospholipid Antibodies (J.H. Rand,
Xiao-Xuan Wu). Antiphospholipid/Endothelial Cell Interaction in the
Pathogenesis of the Antiphospholipid Syndrome (P.L. Luigi et al.). Tissue
Factor, Protein C pathway and other Hemostasis Abnormalities in the
Pathogenesis of the Antiphospholipid Syndrome (R.A.S. Roubey). Systemic
Involvement in the Antiphospholipid Syndrome: Lessons from Animal Models
(Y. Shoenfeld et al.). Cytokines, Th1/Th2 and Adhesion Molecules in the
Antiphospholipid Syndrome (M. Ehrenfeld et al.). Lessons from Monoclonal
Antiphospholipid Antibodies (M. Abu-Shakra, Y. Shoenfeld). Immunogenetics
of the Antiphospholipid Syndrome (G.D. Sebastiani et al.). Pathology of the
Antiphospholipid Syndrome (E. Reyes, D. Alarcón-Segovia). Antiphospholipid
Antibodies in Human and Murine Atherogenesis (Y. Sherer, Y. Shoenfeld).
III. Clinical Features in the Antiphospholipid Syndrome (R. Cervera).
Thrombotic Manifestations in the Antiphospholipid Syndrome (J.O. Ros et al.
). Neurologic Manifestations in the Antiphospholipid Syndrome (R.L. Brey
et al.). Cardiac and Pulmonary Manifestations in the Antiphospholipid
Syndrome (G. Espinosa et al.). Renal, Hepatic and other Intra-abdominal
Manifestations in the Antiphospholipid Syndrome (P. von Landenberg et al.
). Fetal and Obstetric Manifestations and Infertility in the
Antiphospholipid Syndrome (F. Carmona, J. Balasch). Osteo articular
Manifestations in the Antiphospholipid Syndrome (F. Lioté, O. Meyer).
Ophthalmic and Otological Manifestations in the Antiphospholipid Syndrome
(A. Montehermoso et al.). Dermatologic Manifestations in the
Antiphospholipid Syndrome (C. Frances, J.C. Piette). Endocrine
Manifestations in the Antiphospholipid Syndrome (R.A. Asherson, M. Petri).
Hematological Abnormalities in the Antiphospholipid Syndrome (G. Espinosa
et al.). Immunological Abnormalities in the Antiphospholipid Syndrome (A.
Tincani et al.). ''Primary'', ''Secondary'', ''Seronegative'',
''Catastrophic'' and other Subsets of the Antiphospholipid Syndrome (R.A.
Asherson et al.). Pediatric and Familial Antiphospholipid Syndrome (L.R.
Sammaritano, J.-C. Piette). Antiphospholipid Antibodies and Malignancies
(R.A. Asherson et al.). Antiphospholipid Antibodies and Vasculitis (R.A.
Asherson, R.A. Levy). Antiphospholipid Antibodies and Infections-Drugs (G.
Zandman-Goddard et al.). IV. Management and Prognosis of the
Antiphospholipid Syndrome (J.-C. Piette).
Management of Thrombosis in the Antiphospholipid Syndrome (R.H.W.M. Derksen
et al.). Management of Reproductive Failure in the Antiphospholipid
Syndrome (J. Balasch et al.). Management of the Difficult Aspects of the
Antiphospholipid Syndrome (D. Erkan et al.). Course and Prognosis of the
Antiphospholipid Syndrome (C. Drenkard, D. Alarcón-Segovia). Novel
Perspectives in the Treatment of the Antiphospholipid Syndrome - from
Anticoagulation to Immunomodulation (M. Blank et al.). V. Appendix.
The Antiphospholipid Syndrome in the Internet (M. Ramos-Casals, R.
Cervera). A Patient¿s Guide to the Antiphospholipid Syndrome (J. Berman et
al.). Subject Index.
Epidemiology of the Antiphospholipid Syndrome (R.A. Asherson). Milestones
in the Antiphospholipid Syndrome (R.A. Asherson et al.). Classification and
Epidemiology of the Antiphospholipid Syndrome (M. Petri). II. Immunology
and Pathophysiology of the Antiphospholipid Syndrome (Y. Shoenfeld). Lupus
Anticoagulant: Detection, Standardization and Heterogeneity (D.A. Triplett,
M.-C. Boffa). Antibodies to Cardiolipin and other Phospholipids (S.S.
Pierangeli, E.N. Harris). &bgr;-Glycoprotein I and anti-&bgr;-Glycoprotein
I Antibodies (P.G. De Groot et al.). Anti-Prothrombin Antibodies (M.
Galli). The Annexins: A Target of Antiphospholipid Antibodies (J.H. Rand,
Xiao-Xuan Wu). Antiphospholipid/Endothelial Cell Interaction in the
Pathogenesis of the Antiphospholipid Syndrome (P.L. Luigi et al.). Tissue
Factor, Protein C pathway and other Hemostasis Abnormalities in the
Pathogenesis of the Antiphospholipid Syndrome (R.A.S. Roubey). Systemic
Involvement in the Antiphospholipid Syndrome: Lessons from Animal Models
(Y. Shoenfeld et al.). Cytokines, Th1/Th2 and Adhesion Molecules in the
Antiphospholipid Syndrome (M. Ehrenfeld et al.). Lessons from Monoclonal
Antiphospholipid Antibodies (M. Abu-Shakra, Y. Shoenfeld). Immunogenetics
of the Antiphospholipid Syndrome (G.D. Sebastiani et al.). Pathology of the
Antiphospholipid Syndrome (E. Reyes, D. Alarcón-Segovia). Antiphospholipid
Antibodies in Human and Murine Atherogenesis (Y. Sherer, Y. Shoenfeld).
III. Clinical Features in the Antiphospholipid Syndrome (R. Cervera).
Thrombotic Manifestations in the Antiphospholipid Syndrome (J.O. Ros et al.
). Neurologic Manifestations in the Antiphospholipid Syndrome (R.L. Brey
et al.). Cardiac and Pulmonary Manifestations in the Antiphospholipid
Syndrome (G. Espinosa et al.). Renal, Hepatic and other Intra-abdominal
Manifestations in the Antiphospholipid Syndrome (P. von Landenberg et al.
). Fetal and Obstetric Manifestations and Infertility in the
Antiphospholipid Syndrome (F. Carmona, J. Balasch). Osteo articular
Manifestations in the Antiphospholipid Syndrome (F. Lioté, O. Meyer).
Ophthalmic and Otological Manifestations in the Antiphospholipid Syndrome
(A. Montehermoso et al.). Dermatologic Manifestations in the
Antiphospholipid Syndrome (C. Frances, J.C. Piette). Endocrine
Manifestations in the Antiphospholipid Syndrome (R.A. Asherson, M. Petri).
Hematological Abnormalities in the Antiphospholipid Syndrome (G. Espinosa
et al.). Immunological Abnormalities in the Antiphospholipid Syndrome (A.
Tincani et al.). ''Primary'', ''Secondary'', ''Seronegative'',
''Catastrophic'' and other Subsets of the Antiphospholipid Syndrome (R.A.
Asherson et al.). Pediatric and Familial Antiphospholipid Syndrome (L.R.
Sammaritano, J.-C. Piette). Antiphospholipid Antibodies and Malignancies
(R.A. Asherson et al.). Antiphospholipid Antibodies and Vasculitis (R.A.
Asherson, R.A. Levy). Antiphospholipid Antibodies and Infections-Drugs (G.
Zandman-Goddard et al.). IV. Management and Prognosis of the
Antiphospholipid Syndrome (J.-C. Piette).
Management of Thrombosis in the Antiphospholipid Syndrome (R.H.W.M. Derksen
et al.). Management of Reproductive Failure in the Antiphospholipid
Syndrome (J. Balasch et al.). Management of the Difficult Aspects of the
Antiphospholipid Syndrome (D. Erkan et al.). Course and Prognosis of the
Antiphospholipid Syndrome (C. Drenkard, D. Alarcón-Segovia). Novel
Perspectives in the Treatment of the Antiphospholipid Syndrome - from
Anticoagulation to Immunomodulation (M. Blank et al.). V. Appendix.
The Antiphospholipid Syndrome in the Internet (M. Ramos-Casals, R.
Cervera). A Patient¿s Guide to the Antiphospholipid Syndrome (J. Berman et
al.). Subject Index.